Member Info for PM2022

Nomlungu,

You are clearly a bitter loser. I really hope you are not the person that lots of people have suggested to me. An old man Tweeting rubbish who looks like a bitter, sad loser. If that is you what a life you live.

Paperprofits,

Sharing ideas is what this board is all about. New or potential investors learn from LTHs like me and others or experts like Adam.

SItting back and being negative adds zero value. Please think about the points that I make before jumping in. You don't have to agree but that is down to people to decide.

Cenkos warrants are exercisable from tomorrow. The price will need to be above 22p before they can do this.

I think if we get to 22p and if the deal comes which most of us think it will be before the end of September then we should get a few institutional investors buying in and this will increase confidence. They have been working on this from what I understand and they will have an incentive to make big money as well.

Things will get much easier once we get to 22p. Hopefully before the deal. It's all set up and I am sure Suzy will have some big interviews coming up after the deal given we are working with an established marketing firm.

I must say I really enjoyed reading Adam's posts over the weekend. It has taken my level of understanding to a more advanced level than before. This is how I see it based on my own research and learning from Adam:

Val takes on good quality drugs for approximately 100 k and takes it through the evaluation stage. If successful then the value increases into the millions. Approx 10 million value for each drug progressed into the preclinical stage. This stage from evaluation to preclinical only takes about 6-12 months. So far we have TNBC that has progressed so it is worth approx 10 million already and will increase in value as it progresses over the next 1/2 years. We also have two more drugs in the evaluation stage and if either is successful then the value increases by about 10 million each time and more as time goes on. The preclinical drugs can be sold or partnered at any stage from SPV entry but it takes approx 2.5 years to be clinic ready in which case it can get a potential deal worth 100s millions or more if successful.

We have VAL 301 which Val/Japanese have been working on over the last 2 years. Although with some patent issues which can be rectified if the studies are positive it will still likely be at a fairly decent stage. This would likely instantly move us up a very significant amount. I think the news is due for this.

None of the preclinical work was factored in over the last 2 years as we have only just moved our first drug into the preclinical stage under the new strategy.

Our price range over the last 2 years was mainly between 20p-65p. We had a small dilution approx 25% but we were knocked down due to 3 delays, placing fears and a large placing discount . We then added TNBC which is worth approx our market cap alone.

The likelihood of the deal for 201 concluding very soon is very high given that Suzy has gone over all the evidence and feels that it should be concluded soon. Note we opened at 65p after LOI was signed just on this alone excluding any preclinical projects or funding.

I must add I like the fact that they have taken on a marketing firm to help with the publicity and that Adam is more involved. I feel that we should be at least 40-60 p before the 201 deal based on long term trends, TNBC drug being added and more after. Over time I expect the price will get to where it should and with a decent cash balance I am very confident that we will see a multibagger here soon.

Note that Cenkos have warrants at 22 p which would give us approx 1 million in cash and also we would get cash from the 201 deal. That added to the 2.5 million we already have with a low burn rate and zero debt. My personal target is £2-£3 over the next 2 years but even in the short term this has an excellent chance to multibag with very limited risk. I don't see much downside at the current SP and a market cap of 10 million so the risk to reward is the best I have seen so far in my life. All in my opinion.

Worldwide, an estimated 1,414,259 people were diagnosed with prostate cancer in 2020. It is the fourth most commonly diagnosed cancer in the world.

Can you justify to everyone why you don't agree? Based on the size of deals, current market cap and the assets VAL holds and the previous price trends.

Also your posts are full of mistakes as well. Therefore you cannot even walk the talk. Fool.

Lockdowns you claim to do research yet none of your posts suggest this. You lack the ability to think judging from all your posts. It's an outright gamble for you. I would like to have some input as to why you feel VAL is a great investment at 10/11p?

As for the level of education well I am not going to state on public sites what mine is as it is my business. But put it this way my educational background is in science and maths. Specifically Chemistry from a top university and in your case I seriously doubt that you are more educated. It shows how ignorant you are to suggest otherwise.

I generally post to create awareness based on research I have done on VAL. I am no expert but I follow every move. What I find from your posts is that you attempt to disrupt posters and that suggests to me you have an ego problem. You are looking for attention without having any real input. Maybe you were rejected by many people in life and you want to come here to make yourself feel better.

As I stated previously stop twisting what I say. As I stated a few months to a few years is my target but most likely I am looking at 2-3 years hold here . Situations change and I also have price targets and I assess what is happening as time goes on. I feel VAL will get to £2-£3 over the next 2-3 years with a gradual movement. Therefore I will assess the situation as time goes on.

Anyway keep it to VAL please. People don't want to read your posts unless you can discuss the stock. Something you have yet to prove that you have the ability to do.

Great posts from Adam yesterday.

Lockdowns I have said numerous times that I am a LTH so stop twisting what I say. My plan is simply to buy a great stock low and buy heavy and sell months or years later. I can wait for as long as I feel comfortable. I don't believe in chasing rainbows winning , losing and outright gambling from stock to stock and being caught waiting in rubbish stocks without detailed research. Things go up and down but overall I'll walk away having done very well here.

Many stocks on AIM at the moment are suffering from low volumes with a dropping SP, high cash burn rate and therefore at times the likelihood of a large placing at a very low price or going bankrupt. Val has now been through this and is significantly undervalued with a strong cash balance. Therefore in my opinion with lots of news due it is the best investment at this price on AIM.

None of your posts provide any logic, reasoning or research. Have a nice weekend.

Lockdown, Cobalt what do you think of Cineworld? Might suit your investment strategies from what I can see. Nice swings. As always do your own research.

Sporky aka Southern I once saw in your posting history a few months back that you were invested in DDDD and HE1. I think HE1 will be your next one but just a feeling. Best wishes on that one. You are doing really well for sure. Please do let us know all the stocks you invest in.

Irrelevant to discuss the science because they had successful trial results and as it stands the drug works with little side effects. Also Adam has invested and we have investors working on investing 10s millions based on the science to take this forward. That is enough clear and strong evidence for me that this is a valuable drug not to mention all the other ones.

@Chelase well how about a 20 year patent bringing in potential revenues of 100s millions each year. They have considerable experience raising funds. Also as indicated in the end of year RNS that VAL may use them to progress future deals. Getting funds for drugs is the hardest part and most don't get deals.

No offense but you are completely clueless. II investing is likely to happen after a deal if it does happen. If you don't believe in this then move on. We have progressed significantly over the last 1-2 years with TNBC coming in which already is worth many millions and that was not factored in the 20-65p price range. If the deal is concluded it should be higher than that range.

Val might be down but all that means that is a greater rise is likely to happen. Over time things often get corrected back to the correct value. It's not about today or this week but over time even if it is weeks or even months I suspect we will be considerably higher and that is many multiples higher. We shall see.

My price target remains 50-60p by the end of September but if not then it may take a bit longer but it matters not.

So basically you are saying unless a drug gets to phase 3 it is worth zero? So why was VAL mainly in the range 20-65p over the last 2 years and why is every AIM pharma valued as they are with most without drugs on the market.?You never answered any of my questions. If you can buy a phase 2 cancer drug for zero or even 1-2 million then show it to us? My point is we are undervalued and that is not ramping.

Even Synairgen was worth 300 million with no drugs on the market. They had a phase 2 trial running but it's not like the drug was on the market. We have completed phase 2A with positive results with LOI and likely funding. Even if you give 201 low value it is still worth more than our market cap.

Further to add how can the market cap be 10 million when they are prepared to spend 10s million on phase 2b trials and if it fails they lose? That with TNBC worth approx our market cap. We also have another phase 2 drug that works Val 401 and 301 could well be very big.

It's funny how all these idiots like Chelsea cannot justify anything.

Chealsea7 can you find a phase 2 cancer drug that works for 1-2 million anywhere on this planet please? Probably what the market values 201 at that moment. Not to mention the deal part. If you cannot do that then move on.

@Scousegerry that to me indicates news is on the way and they want to maximise the impact to make up for what happened. We are already significantly undervalued which again suggests we will get another mega rise August/Sept this year.

As always buy low and sell high so I think this is a fantastic entry level for a possible 100-500% rise over the next 4-6 weeks imo. Downside 2p from current sp and upside 60-70p with strong publicity from current sp imo over the next 2 months.

When the news drops they will be jumping back in even in the 30s and 40s or when VAL hits headline news. For maximum gains I stay put as I know we are close possibly days/weeks away at most imo.

Ells,

As I explained in my previous posts I have factored that in. In fact I stated we should be minimum 40-50p BEFORE the deal with LOI based on the assets we have and the potential imo. After the deal 70-80p imo but due to current markets 50-60p is more realistic but with good marketing we can hit much higher.

Don't be so dumb. Quite the opposite. I know Hargreaves is very confident.

Some traders might be Hot and Cold but this presents an amazing opportunity. As I said I am happy to wait I know they have sufficient cash to last a long time with plenty of news/ deals to come shortly.

Val is undervalued by a few 100% at the moment BEFORE the deal and at some stage the market will correct the SP. I like the bold move to employ a marketing company. Val would have discussed in detail what they can or cannot do to make sure the SP gets back to where it should be or more. They would only do this if the deal was expected to conclude shortly in my view.

I say VAL 201 alone is worth multiples of our current market cap. We have spent 10s million developing it and the results were extremely encouraging making it much more valuable. It's a cancer drug with the potential to bring revenues of billions if the results are good moving forward.

We have cash for the next 1.5-2 years at least or more if the deal is confirmed as expected shortly with Cenkos warrants giving us even more money and more money from the deal. So potentially we have 2-3 years of cash. I believe the deal is about to be released any time in the next few weeks and the publicity could be the best we have seen in a while on AIM. Not many companies have taken on this strategy.

End of Sept price prediction 50/60p but if we get into a major newspaper or on a main tv channel show then 80p plus just on one deal imo. I suspect they may also get a positive 301 update as well in the coming weeks.